Dyne Therapeutics leverages its FORCE platform to target genetically driven muscle diseases with two lead clinical programs approaching pivotal milestones. DYNE-101 shows strong safety and functional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results